NewProcess Development Engineer, Chemistry Aralez BioProcess Development Engineer, ChemistryBerkeley, CA$80,000–$110,000 / yearPerform "scale-up" and "scale-down" procedures for chemical reactions and unit operations, including optimization and troubleshooting, to ensure successful and efficient transfer from lab-scale (milligram to gram) to pilot-scale (kilogram) and eventual manufacturing scale (multi-kilogram to ton). Execute various chemical unit operations (biocatalytic and chemical reactions, filtrations, purifications, etc.) to produce high-quality noncanonical amino acid products, in collaboration with the Production team.
NewProduction Chemist Kelly ServicesProduction ChemistPleasanton, CAKelly offers eligible employees voluntary benefit plans including medical, dental, vision, telemedicine, term life, whole life, accident insurance, critical illness, a legal plan, and short-term disability. As a Kelly employee, you will have access to a retirement savings plan, service bonus and holiday pay plans (earn up to eight paid holidays per benefit year), and a transit spending account.
Field Chemist II Republic Services, Inc.Field Chemist IISan Jose, CA$39.35–$54.12 / hourPOSITION SUMMARY: The Environmental Field Chemist II role works both indoors and outdoors at various customer sites as a proficient partner to the team to lead safety protocols, package all materials based on required regulations, including onsite testing of suspected materials, and work with the customer to add additional services. Required skills include performing proper waste sampling; creating accurate waste characterizations and profiles; addressing difficult situations in a constructive manner; utilizing computer technology for communication, data gathering and reporting; negotiation and problem solving.
Chemist (Co-Op - Santa Clara) Applied MaterialsChemist (Co-Op - Santa Clara)Santa Clara, CAIf you would like to contact us regarding accessibility of our website or need assistance completing the application process, please contact us via e-mail at Accommodations_Program@amat.com, or by calling our HR Direct Help Line at 877-612-7547, option 1, and following the prompts to speak to an HR Advisor. The salary offered to a selected candidate will be based on multiple factors including location, hire grade, job-related knowledge, skills, experience, and with consideration of internal equity of our current team members.
Staff / Senior Scientist, Assay Development (Chemistry) Glyphic BiotechnologiesStaff / Senior Scientist, Assay Development (Chemistry)Berkeley, California$123,000–$187,575 / yearReporting to the Director of Assay Development, you will be a hands-on expert working at the chemistry-assay interface — developing the chemical methods that enable reliable, high-efficiency sample loading into our expansion assay, and building the novel conjugation, cleavage, and stabilization workflows that power our single-molecule proteome sequencing platform. Demonstrated experience developing site-selective bioconjugation chemistry for native peptides — including N-terminal, C-terminal, and side-chain modification strategies — using click chemistry (CuAAC, SPAAC, IEDDA), NHS-ester coupling, and related bioorthogonal approaches in multi-component peptide systems.
Senior Scientist II, Drug Substance Revolution Medicines, Inc.Senior Scientist II, Drug SubstanceRedwood City, CA$170,000–$212,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The Opportunity: Playing a critical role as a technical lead within the Drug Substance function, the position will be responsible for process research and development and scale-up of manufacturing in support of Revolution Medicines' pipeline compound development, clinical programs and commercial readiness.
Director, Drug Substance Revolution Medicines, Inc.Director, Drug SubstanceRedwood City, CA$211,000–$264,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The Opportunity: Playing a critical role as a technical lead within the Drug Substance function, the position will be responsible for process research and development and scale-up of manufacturing in support of Revolution Medicines' pipeline compound development, clinical programs and commercial readiness.
Chemistry - Graduates - AI Training - San Jose, US Prolific Academic LtdChemistry - Graduates - AI Training - San Jose, USSan Jose, CAWe're looking for Chemistry Experts and Chemical Engineers to join our Expert Network to help train and evaluate cutting-edge AI models using real-world chemical expertise. We've built a unique platform that connects researchers and companies with a global pool of participants, enabling the collection of high-quality, ethically sourced human behavioural data and feedback.
Senior Scientist II, Drug Substance Revolution MedicinesSenior Scientist II, Drug SubstanceRedwood City, CaliforniaThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Playing a critical role as a technical lead within the Drug Substance function, the position will be responsible for process research and development and scale-up of manufacturing in support of Revolution Medicines’ pipeline compound development, clinical programs and commercial readiness.
Director, Drug Substance Revolution MedicinesDirector, Drug SubstanceRedwood City, CaliforniaThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Playing a critical role as a technical lead within the Drug Substance function, the position will be responsible for process research and development and scale-up of manufacturing in support of Revolution Medicines’ pipeline compound development, clinical programs and commercial readiness.
Director of Formulation Chemistry MonarchDirector of Formulation ChemistryOakland, CaliforniaThen applying computational chemistry and machine learning tools to predict which of the billions of potential compounds in nature trigger a ‘fly away’ signal from the olfactory neurons in the antennae to the smell center in the animal’s brain. Monarch is developing a product that works—a spatial repellent that protects crops from insects, humans from toxins, and insects from needless harm.
Senior Product Manager, Chemistry Revolution MedicinesSenior Product Manager, ChemistryRedwood City, CaliforniaYou will partner with medicinal chemists, synthetic chemists, computational chemists, analytical chemists, DMPK and Biology partners, Data Science, ML Engineering, Data Engineering, IT, and platform teams to turn complex Chemistry workflows into intuitive, scalable solutions that accelerate the Design-Make-Test-Learn cycle. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.